DPY30 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.881980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.375400E-01
Normal-vs-Stage2
1.876170E-01
Normal-vs-Stage3
7.060600E-01
Normal-vs-Stage4
1.151400E-01
Stage1-vs-Stage2
6.317800E-01
Stage1-vs-Stage3
6.707200E-01
Stage1-vs-Stage4
3.268400E-01
Stage2-vs-Stage3
3.420600E-01
Stage2-vs-Stage4
3.880600E-01
Stage3-vs-Stage4
2.782000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.927190E-01
Normal-vs-AfricanAmerican
2.132600E-01
Normal-vs-Asian
2.734200E-01
Caucasian-vs-AfricanAmerican
9.423600E-01
Caucasian-vs-Asian
7.182600E-01
AfricanAmerican-vs-Asian
8.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.864240E-01
Normal-vs-Female
1.958830E-01
Male-vs-Female
3.965800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.538000E-01
Normal-vs-Age(41-60Yrs)
9.626100E-02
Normal-vs-Age(61-80Yrs)
2.694000E-01
Normal-vs-Age(81-100Yrs)
2.458400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.610000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.913400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.014400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.030580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.710600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.658000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.926200E-01
Normal-vs-Daily Drinker
2.134200E-01
Normal-vs-Weekly Drinker
4.036800E-01
Normal-vs-Occasional Drinker
2.996100E-02
Normal-vs-Social Drinker
2.761200E-01
Non Drinker-vs-Daily Drinker
5.805400E-01
Non Drinker-vs-Weekly Drinker
3.614800E-01
Non Drinker-vs-Occasional Drinker
5.668200E-02
Non Drinker-vs-Social Drinker
7.879200E-01
Daily Drinker-vs-Weekly Drinker
1.786010E-01
Daily Drinker-vs-Occasional Drinker
2.047600E-01
Daily Drinker-vs-Social Drinker
4.573400E-01
Weekly Drinker-vs-Occasional Drinker
5.816800E-03
Weekly Drinker-vs-Social Drinker
4.979600E-01
Occasional Drinker-vs-Social Drinker
3.670200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.699380E-01
Normal-vs-Grade 2
1.707630E-02
Normal-vs-Grade 3
1.954480E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.911390E-01
Grade 1-vs-Grade 3
3.401700E-02
Grade 1-vs-Grade 4
1.699380E-01
Grade 2-vs-Grade 3
1.624950E-01
Grade 2-vs-Grade 4
1.707630E-02
Grade 3-vs-Grade 4
1.954480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.914800E-01
Normal-vs-NonDiabetic
1.757780E-01
Diabetic-vs-NonDiabetic
3.527600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.385600E-02
Normal-vs-NoPancreatitis
2.276800E-01
Pancreatitis-vs-NoPancreatitis
3.624400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.334840E-01
Normal-vs-N1
1.885430E-01
N0-vs-N1
4.563200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.770100E-02
Normal-vs-TP53-NonMutant
4.524000E-01
TP53-Mutant-vs-TP53-NonMutant
6.30860000017108E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
